HOI LUN HUSAIN: Open Payments
NPI 1821594425 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 61 payments from 16 companies in 2025. Trend: 2023 $705 · 2024 $1,133 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $298 |
| Gilead Sciences, Inc. | 10 | $176 |
| Madrigal Pharmaceuticals | 7 | $144 |
| GlaxoSmithKline, LLC. | 6 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| ABBVIE INC. | 4 | $93 |
| Azurity Pharmaceuticals, Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Exact Sciences Corporation | 2 | $41 |
Products named: FARXIGA, REZDIFFRA, JARDIANCE, Stivarga, DANZITEN, BREZTRI, SHINGRIX, CREON.
Industry payments across NY — which companies pay providers there.
